| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 4 |
| 1 | ETANERCEPT | 4 |
| 2 | INFLIXIMAB | 3 |
| 3 | CISPLATIN | 2 |
| 4 | CYCLOPHOSPHAMIDE | 2 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 2 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 2 |
| 7 | ETOPOSIDE | 2 |
| 8 | HYDROCHLOROTHIAZIDE | 2 |
| 9 | ACYCLOVIR | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DACTINOMYCIN | 1 | 0.0005 |
| 1 | LUTETIUM LU 177 DOTATATE | 1 | 0.0002 |
| 2 | TOPOTECAN | 1 | 0.0002 |
| 3 | UBROGEPANT | 1 | 0.0002 |
| 4 | PAZOPANIB HYDROCHLORIDE | 1 | 0.0000 |
| 5 | LINACLOTIDE | 1 | 0.0000 |
| 6 | IXAZOMIB | 1 | 0.0000 |
| 7 | ERGOCALCIFEROL | 1 | 0.0000 |
| 8 | ETOPOSIDE | 2 | 0.0000 |
| 9 | LACOSAMIDE | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 5 |
| 1 | Topoisomerase Inhibitor [EPC] | 3 |
| 2 | Alkylating Drug [EPC] | 2 |
| 3 | Platinum-based Drug [EPC] | 2 |
| 4 | Thiazide Diuretic [EPC] | 2 |
| 5 | Actinomycin [EPC] | 1 |
| 6 | Amide Local Anesthetic [EPC] | 1 |
| 7 | Antiarrhythmic [EPC] | 1 |
| 8 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 |
| 9 | Calcium [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 1 | Actinomycin [EPC] | 1 | 0.0005 |
| 2 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 3 | Topoisomerase Inhibitor [EPC] | 3 | 0.0000 |
| 4 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 5 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 6 | Ester Local Anesthetic [EPC] | 1 | 0.0000 |
| 7 | Non-Standardized Chemical Allergen [EPC] | 1 | 0.0000 |
| 8 | Amide Local Anesthetic [EPC] | 1 | 0.0000 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |